Join
Live feed
·
INSIDERFilingvia Quantisnow
Calithera Biosciences Inc. logo

SEC Form 4: Orford Keith was granted 30,000 shares and sold $43,520 worth of shares (51,810 units at $0.84), decreasing direct ownership by 13% to 144,284 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CALA (Calithera Biosciences Inc.) and more on Quantisnow.